Companies / BOC Sciences / Envafolimab
BOC Sciences

Envafolimab | BOC Sciences

(0) Write Review

Envafolimab is a recombinant protein of a humanized single-domain anti-PD-L1 antibody. Envafolimab has obtained the U.S. FDA's orphan drug designation for advanced biliary tract cancer.

Reviews

(0) | Be the first to review this product
No reviews yet

ABOUT THE COMPANY

BOC Sciences
BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.
Scientific Products
  • See More
    • Upcoming Virtual Events
    Upcoming Webinars